AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+2.34%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.3B
AUM Growth
+$108M
(+0.96%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
54.77%
Holding
1,167
New
148
Increased
335
Reduced
525
Closed
154
Top Buys
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$124M |
| 2 |
Enterprise Products Partners
EPD
|
+$112M |
| 3 |
MPLX
MPLX
|
+$102M |
| 4 |
Western Midstream Partners
WES
|
+$97.4M |
| 5 |
Energy Transfer Partners
ET
|
+$96.1M |
Top Sells
| 1 |
DCP
DCP Midstream, LP
DCP
|
+$522M |
| 2 |
Cheniere Energy
CQP
|
+$55.3M |
| 3 |
First Solar
FSLR
|
+$18.1M |
| 4 |
Vanguard Consumer Staples ETF
VDC
|
+$13.7M |
| 5 |
Vanguard Total Bond Market
BND
|
+$10.8M |
Sector Composition
| 1 | Energy | 64.06% |
| 2 | Technology | 5.59% |
| 3 | Healthcare | 3.84% |
| 4 | Consumer Discretionary | 3.79% |
| 5 | Financials | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Viking Therapeutics
VKTX
$2.84B
| $861K | 0.01% |
51,718
-325
| -0.6% | -$5.41K |
|
502
Pliant Therapeutics
PLRX
$107M
| $854K | 0.01% |
32,122
-951
| -3% | -$25.3K |
|
503
Freeport-McMoran
FCX
$63B
| $850K | 0.01% |
20,778
+6,648
| +47% | +$272K |
|
504
Recursion Pharmaceuticals
RXRX
$2.05B
| $840K | 0.01% |
126,011
+2,846
| +2% | +$19K |
|
505
National Fuel Gas
NFG
$7.71B
| $839K | 0.01% |
14,537
-2,959
| -17% | -$171K |
|
506
Agios Pharmaceuticals
AGIO
$2.1B
| $837K | 0.01% |
36,422
-823
| -2% | -$18.9K |
|
507
NRG Energy
NRG
$29.5B
| $836K | 0.01% |
24,388
-12,998
| -35% | -$446K |
|
508
Pinterest
PINS
$24.8B
| $831K | 0.01% |
30,470
-6,395
| -17% | -$174K |
|
509
Morningstar
MORN
$10.9B
| $825K | 0.01% |
4,063
+442
| +12% | +$89.7K |
|
510
L3Harris
LHX
$51.2B
| $819K | 0.01% |
4,172
-238
| -5% | -$46.7K |
|
511
Twilio
TWLO
$16.4B
| $813K | 0.01% |
12,198
-23,325
| -66% | -$1.55M |
|
512
Keros Therapeutics
KROS
$628M
| $803K | 0.01% |
18,805
+118
| +0.6% | +$5.04K |
|
513
StepStone Group
STEP
$4.86B
| $796K | 0.01% |
32,800
+3,300
| +11% | +$80.1K |
|
|
LEV
514
DELISTED
The Lion Electric Company
LEV
| $795K | 0.01% |
427,510
-114,817
| -21% | -$214K |
|
515
Brown-Forman Class B
BF.B
$13B
| $782K | 0.01% |
12,170
-646
| -5% | -$41.5K |
|
516
Fulton Financial
FULT
$3.54B
| $781K | 0.01% |
56,546
+15,104
| +36% | +$209K |
|
517
Global Industrial
GIC
$1.48B
| $774K | 0.01% |
+28,826
| New | +$774K |
|
518
Cardinal Health
CAH
$36B
| $765K | 0.01% |
+10,135
| New | +$765K |
|
519
Dr. Reddy's Laboratories
RDY
$12.1B
| $764K | 0.01% |
67,085
+16,585
| +33% | +$189K |
|
520
Tanger
SKT
$3.93B
| $756K | 0.01% |
+38,517
| New | +$756K |
|
521
Sociedad Química y Minera de Chile
SQM
$13B
| $756K | 0.01% |
+9,327
| New | +$756K |
|
522
Invesco
IVZ
$9.81B
| $756K | 0.01% |
46,079
+5,072
| +12% | +$83.2K |
|
523
Protagonist Therapeutics
PTGX
$3.63B
| $746K | 0.01% |
32,415
-934
| -3% | -$21.5K |
|
524
Opko Health
OPK
$1.12B
| $743K | 0.01% |
509,055
-15,537
| -3% | -$22.7K |
|
525
New York Times
NYT
$9.58B
| $742K | 0.01% |
19,085
+2,106
| +12% | +$81.9K |
|